The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: Is it an improvement?

Critical Reviews in Oncology/Hematology

Volumn 47, Issue 2, 2003, Pages 83-89

  Epstein, Jonathan I ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Bladder classification; WHO; WHO ISUP

Indexed keywords

BLADDER TUMOR; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; PAPILLARY CARCINOMA; PAPILLOMA; PROGNOSIS; REVIEW; TUMOR CLASSIFICATION; TUMOR VOLUME; UROGENITAL TRACT TUMOR; WORLD HEALTH ORGANIZATION;

EID: 0043169635     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(03)00073-8     Document Type: Review

References (26)

1. Epstein J.I., Amin M.B., Reuter V.E., Mostofi F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am. J. Surg. Pathol. 12:1998;1435-1448.
2. Taylor D.C., Bhagavan B.S., Larsen M.P., Cox J.A., Epstein J.I. Papillary urothelial hyperplasia. A precursor to papillary neoplasms. Am. J. Surg. Pathol. 20:1996;1481-1488.
3. Swierczinski S.L., Epstein J.I. Prognostic significance of atypical papillary urothelial hyperplasia. Hum Pathol. 33:2002;512-517.
4. Althausen A.F., Prout G.R.J., Dal J.J. Noninvasive papillary carcinoma of the bladder associated with carcinoma in-situ. J. Urol. 116:1976;575-580.
5. Farrow G.M., Utz D.C., Rife C.C. Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. Cancer Res. 36:1976;2495-2501.
6. Koss L.G. Mapping of the urinary bladder: its impact on the concepts of bladder cancer. Hum. Pathol. 10:1979;533-548.
7. Smith G., Elton R.A., Beynon L.L., Newsam J.E., Chisolm G.D., Hargreave T.B. Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer. Br. J. Urol. 55:1983;665-669.
8. Heney N.M., Ahmed S., Flanagan M.J., et al. Superficial bladder cancer: progression and recurrence. J. Urol. 130:1983;1083-1086.
9. Hofstäder F., Delgado R., Jakse G., Judmaier W. Urothelial dysplasia and carcinoma in situ of the bladder. Cancer. 57:1986;356-361.
10. Eble J.N., Young R.H. Benign and low-grade papillary lesions of the urinary bladder: a review of the papilloma-papillary carcinoma controversy and a report of 5 typical papillomas. Semin. Diagn. Pathol. 6:1989;351-371.
11. Broders A.C. Epithelium of the genito-urinary organs. Ann. Surg. 75:1922;574-604.
12. Bergkvist A., Ljungqvist A., Moberger G. Classification of bladder tumours based on the cellular pattern. Acta Chir. Scand. 130:1965;371-378.
13. Mostofi F.K., Sobin L.H., Torloni H. Histological typing of urinary bladder tumours. International classification of tumors 19. 1973;World Health Organization, Geneva.
14. Ooms E.C.M., Anderson W.A.A.D., Alons C.L., Boon M.E., Veldhuizen R.W. Analysis of the performance of pathologists in the grading of bladder tumors. Hum. Pathol. 14:1983;140-143.
15. Jordan A.M., Weingarten J., Murphy W.M. Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? Cancer. 60:1987;2766-2774.
16. Malmström P.-U., Busch C., Norlén B.J. Recurrence, progression and survival in bladder cancer: a retrospective analysis of 232 patients with 5-year follow-up. Scand. J. Urol. Nephrol. 21:1987;185-195.
17. Abel P.D., Henderson D., Bennett, Hall R.R. Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder. Br. J. Urol. 62:1988;339-342.
18. Carbin B.-E., Ekman P., Gustafson H., Christensen N.J., Silfversward C., Sandstedt B. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. II: prognostic importance. J. Urol. 145:1991;972-976.
19. McKenney J.K., Amin M.B., Young R.H. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 25 cases. Mod. Pathol. 15:2002;174A.
20. Cheng L., Newman R.M., Bostwick D.G. Papillary urothelial neoplasms of low malignant potential. Cancer. 86:1999;2102-2108.
21. Desai S., Lim S.D., Jiminez R.E., et al. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Mod. Pathol. 13:2000;1315-1323.
22. Alsheik A., Mohamedali Z., Jones E., et al. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. Mod. Pathol. 14:2001;267-272.
23. Holmang S., Andius P., Hedelin H., et al. Stage progression in TA papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J. Urol. 165:2001;1124-1130.
24. Pich A, Chiusa L, Formiconi A, Galliano D, Bortolini P, Navone R. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder. Am J Surg Pathol 2001 Dec;25: 25:1528-33.
25. Cina S.J., Lancaster-Weiss K.J., Lecksell K., et al. Correlation of ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for urothelial neoplasia. Arch. Pathol. Lab. Med. 125:2001;646-651.
26. Samaratunga H, Makarov DV, Epstein JI. Comparison of WHO/ISUP and WHO classification of non-invasive papillary urothelial neoplasms for risk of progression. Urology, in press.